Changes after publication

Changes after publication

February 2014: implementation section updated to clarify that dexamethasone intravitreal implant is recommended as an option for treating macular oedema secondary to retinal vein occlusion. Additional minor maintenance update also carried out.

  • National Institute for Health and Care Excellence (NICE)